Atlas Trials

A Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation

Clinical trial NCT01797952 · WITHDRAWN

Trial details

NCT number
NCT01797952
Sponsor
All India Institute of Medical Sciences
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Oral Mucositis in Patients Undergoing HSCT
Start date
2015-11-01
Primary completion
2016-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.